Characterization and function of human Ly-6/uPAR molecules

키워드

참고문헌 (100)

1. McKenzie, I. F., "Lymphocyte antigens: Ly-4, Ly-6, and Ly-7", Transplant Proc., 9, pp.667~669 (1977)
2. LeClair, K. P., "Murine Ly-6 multigene family is located on chromosome 15", Proc. Natl. Acad. Sci. U.S.A., 84, pp.1638~1642 (1987)
3. Gumley, T. P., "Tissue expression, structure and function of the murine Ly-6 family of molecules", Immunol. Cell. Biol., 73, pp.277~296 (1995)
4. Li, S. H., "SSLP-1, a secreted Ly-6 protein purified from mouse seminal vesicle fluid", Reproduction, 132, pp.493~500 (2006)
5. Havran, W. L., "Characterization of an anti- Ly-6 monoclonal antibody which defines and activates cytolytic T lymphocytes", J. Immunol., 140, pp.1034~1042 (1988)
6. Davies, A., "CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells", J. Exp. Med., 170, pp.637~654 (1989)
7. Fleming, T. J., "Characterization of two novel Ly-6 genes. Protein sequence and potential structural similarity to alpha-bungarotoxin and other neurotoxins", J. Immunol., 150, pp.5379~5390 (1993)
8. Meri, S., "Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers", Immunology, 71, pp.1~9 (1990)
9. Chang, C. P., "Identity of a peptide domain of human C9 that is bound by the cell-surface complement inhibitor, CD59", J. Biol. Chem., 269, pp.26424~26430 (1994)
10. Treon, S. P., "Treatment of multiple myeloma by antibody mediated immunotherapy and induction of myeloma selective antigens", Ann. Oncol., 11(Suppl 1), pp.107~111 (2000)
11. Naderi, S., "CD2-mediated CD59 stimulation in keratinocytes results in secretion of IL-1alpha, IL-6, and GM-CSF: implications for the interaction of keratinocytes with intraepidermal T lymphocytes", Int. J. Mol. Med., 3, pp.609~614 (1999)
12. Li, B., "The effects of CD59 gene as a target gene on breast cancer cells", Cell Immunol., 272, pp.61~70 (2011)
13. Temerinac, S., "Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is overexpressed in polycythemia rubra vera", Blood, 95, pp.2569~2576 (2000)
14. Sachs, U. J., "The neutrophil-specific antigen CD177 is a counter-receptor for platelet endothelial cell adhesion molecule-1 (CD31)", J. Biol. Chem., 282, pp.23603~23612 (2007)
15. Dillon, M., "Expression of the GPI-anchored receptor Prv-1 enhancesthrombopoietin and IL-3-induced proliferation inhematopoietic cell lines", Leuk Res., 32, pp.811~819 (2008)
16. Korkmaz, B., "A hydrophobic patch on proteinase 3, the target of autoantibodies in Wegener granulomatosis, mediates membrane binding via NB1 receptors", J. Biol. Chem., 283, pp.35976~35982 (2008)
17. Beigneux, A. P., "Glycosylphosphatidylinositol-anchored high-density lipoprotein- binding protein 1 plays a critical role in the lipolytic processing of chylomicrons", Cell Metab., 5, pp.279~291 (2007)
18. Davies, B. S., "GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries", Cell Metab., 12, pp.42~52 (2010)
19. Quak, J. J., "A 22-kd surface antigen detected by monoclonal antibody E 48 is exclusively expressed in stratified squamous and transitional epithelia", Am. J. Pathol., 136, pp.191~197 (1990)
20. Bartelink, H., "Progress in radiotherapy by treatment tailoring in head and neck cancer", Curr. Opin. Oncol., 3, pp.523~528 (1991)
21. Nieuwenhuis, E. J., "Assessment and clinical significance of micrometastases in lymph nodes of head and neck cancer patients detected by E48 (Ly-6D) quantitative reverse transcription-polymerase chain reaction", Lab. Invest., 83, pp.1233~1240 (2003)
22. Antica, M., "Stem cell antigen2 expression in adult and developing mice", Immunol.Lett., 55, pp.47~51 (1997)
23. Noda, S., "Protection from anti-TCR", CD3-induced apoptosis in immature thymocytes by a signal through thymic shared antigen-1, J. Exp. Med., pp.1996, 183[DOI]
24. Saitoh, S., "Modulation of TCR-mediated signaling pathway by thymic shared antigen-1 (TSA-1)", stem cell antigen-2 (Sca-2), 1995, pp.155, 5574~5581
25. Bresson-Mazet, C., "Stem cell antigen 2: a new gene involved in theself-renewal of erythroid progenitors", Cell Prolif., 41, pp.726~738 (2008)
26. Horie, M., "Isolation and characterization of a new member of the human Ly6 gene family (LY6H)", Genomics, 53, pp.365~368 (1998)
27. de Nooij-van Dalen, A. G., "Characterization of the human Ly-6 antigens, the newly annotated member Ly-6K included, as molecular markers for head-and-neck squamous cell carcinoma", Int. J. Cancer, 103, pp.768~774 (2003)
28. Lee, J. W., "LY-6K gene: a novel molecular marker for human breast cancer", Oncol. Rep., 16, pp.1211~1214 (2006)
29. Ishikawa, N., "Cancer-testis antigen lymphocyte antigen 6 complex locus K is a serologic biomarker and a therapeutic target for lung and esophageal carcinomas", Cancer Res., 67, pp.11601~11611 (2007)
30. Matsuda, R., "LY6K is a novel molecular target in bladder cancer on basis of integrate genome- wide profiling", Br. J. Cancer, 104, pp.376~386 (2011)
31. Zhang, B., "Serological antibodies against LY6K as a diagnostic biomarker in esophageal squamous cell carcinoma", Biomarkers, 17, pp.372~378 (2012)
32. 공현경, "Metastatic effect of LY-6K gene in breast cancer cells", International Journal of Oncology, 35(3), pp.601~607 (2009), Demetrios A. Spandidos Ed. & Pub.
33. Suda, T., "Identification of human leukocyte antigen-A24-restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapy", Cancer Sci., 98, pp.1803~1808 (2007)
34. Yu, D. H., "PHTS, a novel putative tumor suppressor, is involved in the transformation reversion of HeLaHF cells independently of the p53 pathway", Exp. Cell Res., 312, pp.865~876 (2006)
35. Egerod, K. L., "GPR39 splice variants versus antisense gene LYPD1: expression and regulation in gastrointestinal tract, endocrine pancreas, liver, and white adipose tissue", Mol. Endocrinol., 21, pp.1685~1698 (2007)
36. Wurfel, J., "Cloning of the human homologue of the metastasis-associated rat C4.4A", Gene, 262, pp.35~41 (2001)
37. Seiter, S., "Upregulation of C4.4A expression during progression of melanoma", J. Invest. Dermatol., 116, pp.344~347 (2001)
38. Fletcher, G. C., "hAG-2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4a and dystroglycan", Br. J. Cancer, 88, pp.579~585 (2003)
39. Paret, C., "C4.4A as a candidate marker in the diagnosis of colorectal cancer", Br. J. Cancer, 97, pp.1146~1156 (2007)
40. Hansen, L. V., "Tumour cell expression of C4.4A, a structural homologueof the urokinase receptor, correlates with poorprognosis in non-small cell lung cancer", Lung Cancer, 58, pp.260~266 (2007)
41. Hansen, L. V., "Altered expression of the urokinase receptor homologue, C4.4A, in invasive areas of human esophageal squamous cell carcinoma", Int. J. Cancer, 122, pp.734~741 (2008)
42. Oshiro, R., "C4.4A is associated with tumor budding and epithelial- mesenchymal transition of colorectal cancer", Cancer Sci., 103, pp.1155~1164 (2012)
43. Ngora, H., "Membrane-bound and exosomal metastasis-associatedC4.4A promotes migration by associating with thealpha(6)beta(4) integrin and MT1-MMP", Neoplasia, 14, pp.95~107 (2012)
44. Zhang, Y., "Identification and characterization of humanLYPD6, a new member of the Ly-6 superfamily", Mol. Biol.Rep., 37, pp.2055~2062 (2010)
45. Ni, J., "Cloning and characterization of a human LYPD7, a new member of the Ly-6 superfamily", Mol. Biol. Rep., 36, pp.697~703 (2009)
46. Reiter, R. E., "Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer", Proc. Natl. Acad. Sci. U.S.A., 95, pp.1735~1740 (1998)
47. Argani, P., "Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma", Cancer Res., 61, pp.4320~4324 (2001)
48. Amara, N., "Prostate stem cell antigen is overexpressed in human transitional cell carcinoma", Cancer Res., 61, pp.4660~4665 (2001)
49. Elsamman, E. M., "The expression of prostate stem cell antigen in human clear cell renal cell carcinoma: a quantitative reverse transcriptase- polymerase chain reaction analysis", BJU Int., 98, pp.668~673 (2006)
50. Sakamoto, H., "Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer", Nat. Genet., 40, pp.730~740 (2008)
51. Liu, W. K., "Expression of PSCA, PIWIL1, and TBX2 in endometrial adenocarcinoma", Onkologie, 33, pp.241~245 (2010)
52. Kawaguchi, T., "Clinical significance of prostate stem cell antigen expression in non-small cell lung cancer", Jpn. J. Clin. Oncol., 40, pp.319~326 (2010)
53. Liu, W. K., "Expression of PSCA, PIWIL1 and TBX2 and its correlation with HPV16 infection in formalin-fixed, paraffin-embedded cervical squamous cell carcinoma specimens", Arch. Virol., 155, pp.657~663 (2010)
54. Hao, J. Y., "PSCA expression in invasive micropapillary carcinoma of breast", Zhonghua Bing Li Xue Za Zhi, 40, pp.382~386 (2011)
55. Geiger, K. D., "The prostate stem cell antigen represents a novel glioma-associated antigen", Oncol Rep., 26, pp.13~21 (2011)
56. Bahrenberg, G., "Reduced expression of PSCA, a member of theLY-6 family of cell surface antigens, in bladder, esophagus,and stomach tumors", Biochem. Biophys. Res.Commun., 275, pp.783~788 (2000)
57. 이연수, "Prostate Stem Cell Antigen, a Presumable Organ-Dependent Tumor Suppressor Gene, is Down-Regulated in Gallbladder Carcinogenesis", GENES CHROMOSOMES CANCER, 51(1), pp.30~41, WILEY-BLACKWELL
58. Wu, X., "Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer", Nat. Genet., 41, pp.991~995 (2009)
59. Matsuo, K., "Association of prostate stem cell antigen gene polymorphisms with the risk of stomach cancer in Japanese", Int. J. Cancer, 125, pp.1961~1964 (2009)
60. Kim, S. Y., "Prostate Stem Cell Antigen Single Nucleotide Polymorphisms Influence Risk of Estrogen Receptor Negative Breast Cancer in Korean Females", ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 13(1), pp.41~48 (2012), ASIAN PACIFIC ORGANIZATION CANCER PREVENTION
61. Saffran, D. C., "Anti-PSCA mAbs inhibit tumor growth and metastasis formation and prolong the survival of mice bearing human prostate cancer xenografts", Proc. Natl. Acad. Sci. U.S.A., 98, pp.2658~2663 (2001)
62. Feng, H. C., "Overexpression of prostate stem cell antigen is associated with gestational trophoblastic neoplasia", Histopathology, 52, pp.167~174 (2008)
63. Moore, M. L., "Deletion of PSCA increases metastasis of TRAMP-induced prostate tumors without altering primary tumor formation", Prostate, 68, pp.139~151 (2008)
64. Marra, E., "Growth delay of human bladder cancer cells by Prostate Stem Cell Antigen downregulation is associated with activation of immune signaling pathways", BMC Cancer, 10, pp.129~ (2010)
65. Shetty, J., "SAMP14, a novel, acrosomal membrane-associated, glycosylphosphatidylinositol-anchored member of the Ly-6", urokinase-type plasminogen activator receptor superfamily with a role in sperm-egg interaction, 2003, pp.278, 30506~30515
66. Adermann, K., "Structural and phylogenetic characterization of human SLURP-1, the first secreted mammalian member of the Ly-6", uPAR protein superfamily, 1999, pp.8, 810~819
67. Fischer, J., "Mutations in the gene encoding SLURP-1 in Mal de Meleda", Hum. Mol. Genet, 10, pp.875~880 (2001)
68. Tsuji, H., "SLURP-2, a novel member of the human Ly-6 superfamily that is up-regulated in psoriasis vulgaris", Genomics, 81, pp.26~33 (2003)
69. Arredondo, J., "Biological effects of SLURP-1 on human keratinocytes", J. Invest. Dermatol., 125, pp.1236~1241 (2005)
70. Pettersson, A., "Expression of the endogenous, nicotinic acetylcholine receptor ligand, SLURP-1, in human colon cancer", Auton Autacoid. Pharmacol., 28, pp.109~116 (2008)
71. Phan, T. C., "A novel molecule, SLURP-1, enhances the survival of periodontal ligament fibroblasts", J. Periodontal. Res., 45, pp.331~336 (2010)
72. Tjiu, J. W., "SLURP1 mutation-impaired T-cell activation in a family with mal de Meleda", Br. J. Dermatol., 164, pp.47~53 (2011)
73. Arredondo, J., "SLURP-2: A novel cholinergic signaling peptide in human mucocutaneous epithelium", J. Cell. Physiol., 208, pp.238~245 (2006)
74. Moriwaki, Y., "Immune system expression of SLURP-1 and SLURP-2, two endogenous nicotinic acetylcholine receptor ligands", Life Sci., 80, pp.2365~2368 (2007)
75. Anderson, D. J., "Monoclonal antibodies to human trophoblast and sperm antigens: report of two WHO-sponsored workshops, June 30, 1986--Toronto, Canada", J. Reprod. Immunol., 10, pp.231~257 (1987)
76. Herr, J. C., "Biochemical and morphological characterization of the intra-acrosomal antigen SP-10 from human sperm", Biol. Reprod., 42, pp.181~193 (1990)
77. Kurth, B. E., "Localization of sperm antigen SP-10 during the sixstages of the cycle of the seminiferous epithelium in man", Biol. Reprod., 44, pp.814~821 (1991)
78. Vassalli, J. D., "A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase", J. Cell Biol., 100, pp.86~92 (1985)
79. Mondino, A., "Structure and function of the urokinase receptor", Thromb Haemost, 82(Suppl 1), pp.19~22 (1999)
80. Schlechte, W., "Examination of the role of the urokinase receptor in human colon cancer mediated laminin degradation", Cancer Res., 49, pp.6064~6069 (1989)
81. Del Vecchio, S., "Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography: comparison with urokinase levels", Cancer Res., 53, pp.3198~3206 (1993)
82. de Vries, T. J., "Plasminogen activa-tors, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression", Am. J. Pathol., 144, pp.70~81 (1994)
83. Mohanam, S., "Proteolysis and invasiveness of brain tumors: role of urokinase-type plasminogen activator receptor", J. Neurooncol., 22, pp.153~160 (1994)
84. Pedersen, H., "Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue", Cancer Res., 54, pp.4671~4675 (1994)
85. Wagner, S. N., "Modulation of urokinase and urokinase receptor gene expression in human renal cell carcinoma", Am. J. Pathol., 147, pp.183~192 (1995)
86. Morita, Y., "Expression of urokinase-type plasminogen activator receptor in hepatocellular carcinoma", Hepatology, 25, pp.856~861 (1997)
87. Yonemura, Y., "Correlation between expression of urokinase-type plasminogen activator receptor and metastasis in gastric carcinoma", Oncol. Rep., 4, pp.1229~1234 (1997)
88. Sier, C. F., "The level of urokinase-type plasminogen activator receptor is increased in serum of ovarian cancer patients", Cancer Res., 58, pp.1843~1849 (1998)
89. Schmidt, M., "Increased levels of urokinase receptor in plasma of head and neck squamous cell carcinoma patients", Acta. Otolaryngol., 119, pp.949~953 (1999)
90. Nozaki, S., "Inhibition of invasion and metastasis in oral cancer by targeting urokinase- type plasminogen activator receptor", Oral Oncol., 41, pp.971~977 (2005)
91. Wang, J., "Expression of urokinase-type plasminogen activator receptor is correlated with metastases of lingual squamous cell carcinoma", Br. J. Oral. Maxillofac. Surg., 44, pp.515~519 (2006)
92. Hildenbrand, R., "Amplification of the urokinase-type plasminogen activator receptor (uPAR) gene in ductal pancreatic carcinomas identifies a clinically high-risk group", Am. J. Pathol., 174, pp.2246~2253 (2009)
93. Ossowski, L., "Urokinase receptor and integrin partnership: coordination of signaling for cell adhesion, migration and growth", Curr. Opin. Cell Biol., 12, pp.613~620 (2000)
94. Nykjaer, A., "Urokinase receptor. An activation antigen in human T lymphocytes", J. Immunol., 152, pp.505~516 (1994)
95. Gyetko, M. R., "Function of the urokinase receptor (CD87) in neutrophil chemotaxis", J. Leukoc. Biol., 58, pp.533~538 (1995)
96. Pedersen, N., "A ligand-free, soluble urokinase receptor is present in the ascitic fluid from patients with ovarian cancer", J. Clin. Invest., 92, pp.2160~2167 (1993)
97. Rigolin, G. M., "Soluble urokinase-type plasminogen activator receptor (suPAR) as an independent factor predicting worse prognosis and extra- bone marrow involvement in multiple myeloma patients", Br. J. Haematol., 120, pp.953~959 (2003)
98. Nijziel, M. R., "The prognostic value of the soluble urokinase-type plasminogen activator receptor (s-uPAR) in plasma of breast cancer patients with and without metastatic disease", J. Thromb. Haemost., 1, pp.982~986 (2003)
99. Saitou, N., "The neighbor-joining method: a new method for reconstructing phylogenetic trees", Mol. Biol. Evol., 4, pp.406~425 (1987)
100. Whelan, S., "A general empirical model of protein evolution derived from multiple protein families using a maximum-likelihood approach", Mol. Biol. Evol., 18, pp.691~699 (2001)

관련 논문AI추천